The purpose of this research study is to understand the long-term effects of COVID-19
infection on individuals without any prior history of diabetes. This study will look at
several measures of diabetes, such as glycemic control (blood glucose/sugar levels),
function of beta cells (cells that make insulin to control sugar), insulin secretion and
insulin sensitivity (fasting insulin levels).
The following participants will be enrolled: 1) have had COVID-19 infection and were
hospitalized and recovered, or 2) have had mild COVID-19 infection and were seen at
outpatient clinics or ER and were not required to be hospitalized, or 3) have not had
COVID-19 infection but were seen in outpatient clinics or ER during the same time period.
The researchers hope to learn the long-term effects of COVID-19 infection in hospitalized
patients. Specifically, they will be focusing on the subsequent development of diabetes
and associated metabolic disturbances, such as impaired insulin secretion and insulin
resistance. A relationship between COVID-19 and diabetes needs to be investigated.
How understandable was the trial content above?
Hard to understand
Easy to understand